Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe covid19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT04403035
What this trial is testing

Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19

Who this might be right for
Covid-19
Henry Ford Health System
Testing effectiveness (Phase 2)UnknownNCT04846010
What this trial is testing

Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2

Who this might be right for
Sequelae of; InfectionPost Infection GlomerulonephritisPost-Infectious Peripheral Neuralgia+15 more
All Natural Medicine Clinic, LLC 2,000
Large-scale testing (Phase 3)Study completedNCT04442048
What this trial is testing

Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure

Who this might be right for
CancerCovid-19
Canadian Cancer Trials Group 195
Large-scale testing (Phase 3)Study completedNCT06729606
What this trial is testing

Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

Who this might be right for
Covid19
National Institute of Allergy and Infectious Diseases (NIAID) 471
Not applicableStudy completedNCT03831906
What this trial is testing

Impact of Systematic Early Tuberculosis Detection Using Xpert MTB/RIF Ultra in Children With Severe Pneumonia in High Tuberculosis Burden Countries (TB-Speed Pneumonia)

Who this might be right for
TuberculosisSevere PneumoniaCovid19
Institut National de la Santé Et de la Recherche Médicale, France 2,570
Testing effectiveness (Phase 2)Study completedNCT04551898
What this trial is testing

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Covid19
BeiGene 181
Not applicableUnknownNCT04517136
What this trial is testing

Impact of Perceived Control on Operational Strain: a Study of COVID-19 Pandemic Caregivers and Military Personnel on Operational Missions

Who this might be right for
Covid19SARS-CoV InfectionBurnout, Caregiver+1 more
Direction Centrale du Service de Santé des Armées 39
Testing effectiveness (Phase 2)UnknownNCT04331613
What this trial is testing

Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS

Who this might be right for
COVID-19Acute Respiratory Distress SyndromeVirus; Pneumonia+1 more
Chinese Academy of Sciences 9
Not applicableStudy completedNCT07466524
What this trial is testing

SuPAR Michigan M2C2 Heterogeneity Validation Cohort Study

Who this might be right for
COVID-19Severe Respiratory Distress SyndromeAcute Respiratory Distress Syndrome
ViroGates A/S 367
Not applicableUnknownNCT04392089
What this trial is testing

Effects of Cardiovascular and Pulmonary Optimization on Cerebral Oxygenation in COVID-19 Patients With Severe ARDS

Who this might be right for
COVID-19Respiratory Failure
Hvidovre University Hospital 20
Not applicableUnknownNCT04948242
What this trial is testing

Characteristics of Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection (COVID-19)

Who this might be right for
SARS-CoV2 Infection
Hospital Universitari Joan XXIII de Tarragona. 5,000
Testing effectiveness (Phase 2)Study completedNCT04357782
What this trial is testing

Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation

Who this might be right for
COVID-19Hypoxia
Hunter Holmes Mcguire Veteran Affairs Medical Center 20
Not applicableStudy completedNCT04423770
What this trial is testing

COVID-19 Related Health and Infection Control Practices Among Dentists

Who this might be right for
Severe Acute Respiratory Syndrome Coronavirus 2
American Dental Association 2,196
Not applicableUnknownNCT04273646
What this trial is testing

Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Severe COVID-19

Who this might be right for
2019 Novel Coronavirus PneumoniaCOVID-19
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 48
Not applicableWithdrawnNCT04878042
What this trial is testing

COVID-19 Infection Control Using H2O2 Mouth Wash and Nasal Spray

Who this might be right for
COVID-19
EPISTATA
Not applicableStudy completedNCT06287554
What this trial is testing

Effect of Early Implementation of Prone Positioning

Who this might be right for
Severe Acute Respiratory Syndrome
Zulekha Hospitals 70
Not applicableStudy completedNCT04446286
What this trial is testing

Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19

Who this might be right for
Covid-19
University Hospital, Strasbourg, France 50
Testing effectiveness (Phase 2)Study completedNCT04357366
What this trial is testing

SuPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE)

Who this might be right for
COVID-19Virus DiseasesCorona Virus Infection+1 more
Hellenic Institute for the Study of Sepsis 1,000
Testing effectiveness (Phase 2)WithdrawnNCT05702788
What this trial is testing

Efficacy and Safety of Jaktinib in Participants With Severe Novel Coronavirus Pneumonia(COVID-19)

Who this might be right for
COVID-19Pneumonia
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Testing effectiveness (Phase 2)Study completedNCT04606069
What this trial is testing

Treat COVID-19 Patients With Regadenoson

Who this might be right for
COVID-19Lung Inflammation
University of Maryland, Baltimore 5
Next Page